JPH04341180A - Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof - Google Patents

Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof

Info

Publication number
JPH04341180A
JPH04341180A JP3139470A JP13947091A JPH04341180A JP H04341180 A JPH04341180 A JP H04341180A JP 3139470 A JP3139470 A JP 3139470A JP 13947091 A JP13947091 A JP 13947091A JP H04341180 A JPH04341180 A JP H04341180A
Authority
JP
Japan
Prior art keywords
acid
unsaturated fatty
fatty acids
lactic acid
highly unsaturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3139470A
Other languages
Japanese (ja)
Inventor
Kazuyoshi Yazawa
一良 矢澤
Kazuo Watabe
渡部 和郎
Masanori Saito
政則 斉藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Original Assignee
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute filed Critical Sagami Chemical Research Institute
Priority to JP3139470A priority Critical patent/JPH04341180A/en
Priority to JP4147946A priority patent/JPH05304967A/en
Publication of JPH04341180A publication Critical patent/JPH04341180A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To effectively produce the subject lactic acid bacterium holding the original usefulness thereof, and further, facilitating the intake of a highly unsaturated fatty acid having a high nutritional and pharmacological value by culturing the lactic acid bacterium in a medium containing the highly unsaturated fatty acid. CONSTITUTION:Lactic acid bacterium is cultured in a medium containing a highly unsaturated fatty acid (e.g. linoleic acid or linolenic acid) or a fat or oil containing the unsaturated fatty acid (preferably an oil extracted from blue back fishes) to provide the objective lactic acid bacterium. The addition of the fat or oil to the medium in an amount of 0.002-0.1% is preferable, because the multiplication degree of the lactic acid bacterium and the intake degree of the highly unsaturated fatty acid are improved.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は、高度不飽和脂肪酸類を
含有する乳酸菌及びその製造方法に関するものである。 該乳酸菌は食品、化粧品、農業、水産、化成品などの分
野において有用である。
TECHNICAL FIELD The present invention relates to lactic acid bacteria containing highly unsaturated fatty acids and a method for producing the same. The lactic acid bacteria are useful in fields such as foods, cosmetics, agriculture, fisheries, and chemical products.

【0002】0002

【従来の技術】乳酸菌は本来有している薬理作用として
、■腸内で増殖し、有害菌の定着を阻止する物質を産生
したり、有害菌の定着場所を占拠する、■腸内では増殖
しないが、その菌体成分が有効物質として働き、直接生
体の免疫力を高めたり、コレステロールの吸収を阻止し
たり、あるいは腸内菌叢の改善に作用する、■腸内にお
いて腸内有害菌によって生成される菌体内毒素、エンテ
ロトキシン、アミン、アンモニアなどの生成を抑制する
、等により広く利用されているが、その菌体脂肪酸組成
の成分はパルミチン酸、パルミトオレイン酸、オレイン
酸が主であって、これらの脂肪酸の栄養的、薬理的価値
は乏しい。尚、高度不飽和脂肪酸は一切含有されていな
い。
[Prior art] Lactic acid bacteria have inherent pharmacological actions such as: ■ Proliferate in the intestine, produce substances that prevent the colonization of harmful bacteria, and occupy the colonization site of harmful bacteria. ■ Proliferate in the intestine. However, the bacterial components act as active substances, directly increasing the body's immunity, blocking the absorption of cholesterol, or improving the intestinal flora. It is widely used to suppress the production of bacterial intratoxins, enterotoxins, amines, ammonia, etc., but its bacterial fatty acid composition is mainly palmitic acid, palmitooleic acid, and oleic acid. Therefore, these fatty acids have poor nutritional and pharmacological value. Furthermore, it does not contain any highly unsaturated fatty acids.

【0003】一方、リノール酸、アラキドン酸などの高
度不飽和脂肪酸はエイコサノイド前駆体として重要であ
る他、成長促進、皮膚湿潤作用などが知られている。 又、α−リノレイン酸、エイコサペンタエン酸、ドコサ
ヘキサエン酸などのω3系列の高度不飽和脂肪酸はω6
系列の高度不飽和脂肪酸にきっこうするエイコサノイド
前駆体として抗血栓、抗腫瘍、抗動脈硬化、抗炎症など
の作用の他、脂質低下作用や特にドコサヘキサエン酸に
おいては視力低下抑制、記憶改善などの作用が知られて
いる。これらの高度不飽和脂肪酸はいずれも必須脂肪酸
である。ω6系列の高度不飽和脂肪酸は陸棲の動物油脂
、植物の根等に含まれており、現在の食生活において十
分摂取可能であるが、ω3系列の高度不飽和脂肪酸、特
にエイコサペンタエン酸やドコサヘキサエン酸は海産生
物に特有の脂肪酸であり、肉食嗜好にある世代にとって
は不足しがちである。海産生物由来の食品が避けられが
ちである大きな要因はその芳香である。エイコサペンタ
エン酸やドコサヘキサエン酸も海産物の芳香の一成分で
あるが、それは酸化分解生成物のアルデヒドに由来する
。従って、これらの高度不飽和脂肪酸の酸化が困難な形
状で食品に添加できることが好ましい。
On the other hand, highly unsaturated fatty acids such as linoleic acid and arachidonic acid are important as eicosanoid precursors, and are also known to have growth promoting and skin moisturizing effects. In addition, ω3 series highly unsaturated fatty acids such as α-linoleic acid, eicosapentaenoic acid, and docosahexaenoic acid are ω6
As an eicosanoid precursor associated with polyunsaturated fatty acids in the series, it has antithrombotic, antitumor, antiarteriosclerotic, and antiinflammatory effects, as well as lipid-lowering effects, and especially docosahexaenoic acid, which has effects such as suppressing vision loss and improving memory. Are known. All of these highly unsaturated fatty acids are essential fatty acids. Omega-6 series polyunsaturated fatty acids are found in terrestrial animal fats and oils, plant roots, etc., and can be consumed in sufficient amounts in the current diet, but omega-3 series polyunsaturated fatty acids, especially eicosapentaenoic acid and docosahexaenoic acid, is a fatty acid unique to marine organisms, and people of the generation who prefer meat eating tend to be deficient in it. A major reason why foods derived from marine organisms tend to be avoided is their aroma. Eicosapentaenoic acid and docosahexaenoic acid are also components of the aroma of seafood, but they are derived from aldehydes, which are oxidative decomposition products. Therefore, it is preferable that these highly unsaturated fatty acids can be added to foods in a form that is difficult to oxidize.

【0004】0004

【発明が解決しようとする課題】本発明の目的は、乳酸
菌の本来の有用性を保持すると共に、栄養上、薬理上価
値のある高度不飽和脂肪酸を摂取し易くするために高度
不飽和脂肪酸類を含有する乳酸菌を提供することにある
[Problems to be Solved by the Invention] It is an object of the present invention to maintain the original usefulness of lactic acid bacteria and to improve the production of polyunsaturated fatty acids in order to facilitate the intake of nutritionally and pharmacologically valuable polyunsaturated fatty acids. An object of the present invention is to provide lactic acid bacteria containing the following.

【0005】[0005]

【課題を解決するための手段】本発明者らは、上記の目
的のために鋭意研究の結果、培地中に高度不飽和脂肪酸
類を含む油脂を添加して培養した乳酸菌の脂質について
、次のような知見を得た。即ち、■高度不飽和脂肪酸含
有乳酸菌菌体を蒸留水、界面活性剤、塩酸で洗浄しても
、該菌体中の高度不飽和脂肪酸が総脂肪酸の30%以上
と高いこと、■本発明で用いる乳酸菌の増殖速度は早く
、多量の菌体を短時間の中に得ることができる。
[Means for Solving the Problems] As a result of intensive research for the above purpose, the present inventors have discovered the following regarding the lipids of lactic acid bacteria cultured by adding fats and oils containing highly unsaturated fatty acids to the medium. I gained this knowledge. That is, (1) Even if the cells of lactic acid bacteria containing highly unsaturated fatty acids are washed with distilled water, a surfactant, and hydrochloric acid, the polyunsaturated fatty acids in the cells are as high as 30% or more of the total fatty acids; (2) The present invention The lactic acid bacteria used have a fast growth rate, and a large amount of bacterial cells can be obtained in a short period of time.

【0006】本発明は、以上のような知見に基づいて完
成されたもので、乳酸菌を高度不飽和脂肪酸類又はそれ
らを含む油脂を添加した培地中にて培養することを特徴
とする高度不飽和脂肪酸類を含有する乳酸菌及びその製
造方法である。
The present invention was completed based on the above findings, and is characterized by culturing lactic acid bacteria in a medium supplemented with highly unsaturated fatty acids or fats and oils containing them. Lactic acid bacteria containing fatty acids and a method for producing the same.

【0007】本発明で用いる高度不飽和脂肪酸類として
は、リノール酸、γ−リノレイン酸、アラキドン酸、α
−リノレイン酸、エイコサペンタエン酸、ドコサヘキサ
エン酸及びこれらの塩類、エステル類、トリアシルグリ
セロール、ジアシルグリセロール、モノアシルグリセロ
ール、グリセロリン脂質、グリセロ糖脂質、スフィンゴ
リン脂質、スフィンゴ糖脂質等が挙げられる。
The highly unsaturated fatty acids used in the present invention include linoleic acid, γ-linoleic acid, arachidonic acid, and α-linoleic acid.
-Linoleic acid, eicosapentaenoic acid, docosahexaenoic acid and their salts, esters, triacylglycerol, diacylglycerol, monoacylglycerol, glycerophospholipid, glyceroglycolipid, sphingophospholipid, glycosphingolipid and the like.

【0008】これらの高度不飽和脂肪酸を含む油脂とし
ては、好ましくは総脂肪酸中の高度不飽和脂肪酸の占め
る割合が10%以上のものが良く、このようなものの例
を上げるとイワシ、サバ、アジなどの青背魚より抽出し
た油脂、マグロやカツオなどの大型海産魚の眼窩脂肪由
来の油脂、微生物由来の油脂、イカ肝臓より抽出した海
産物由来の油脂などが好ましい例としてあげられる。
[0008] The oils and fats containing these highly unsaturated fatty acids are preferably those in which the proportion of highly unsaturated fatty acids in the total fatty acids is 10% or more, and examples of such oils include sardines, mackerel, and horse mackerel. Preferred examples include oils and fats extracted from blue-backed fish such as tuna and bonito, oils and fats derived from the orbital fat of large marine fish such as tuna and bonito, oils and fats derived from microorganisms, and oils and fats derived from marine products extracted from squid liver.

【0009】本発明で利用できる乳酸菌は特に属、種あ
るいは株などを限定されるものではないが、例えばエン
テロコッカス属、ラクトバチルス属、ビヒドバクテリウ
ム属が挙げられる。これらの乳酸菌については公的微生
物寄託機関などにて容易に入手できる。
[0009] The lactic acid bacteria that can be used in the present invention are not particularly limited in genus, species, or strain, but include, for example, Enterococcus, Lactobacillus, and Bihydrobacterium. These lactic acid bacteria can be easily obtained from public microorganism depositories.

【0010】本発明の実施に当たっては、乳酸菌を常法
により例えば培地で培養し、これを遠心分離法で集め、
洗浄、乾燥して乳酸菌粉末を得る。この際の培地として
は例えば次の第1表に示す組成の培地を調製することが
できる。
[0010] In carrying out the present invention, lactic acid bacteria are cultured using a conventional method, for example, in a medium, and collected by centrifugation.
Wash and dry to obtain lactic acid bacteria powder. As the culture medium at this time, for example, a culture medium having the composition shown in Table 1 below can be prepared.

【0011】                          
     第1表    ─────────────
─────────────────        
  BHI(DIFCO)             
       3.7     %         
         仔牛脳浸出物          
          1.6     %      
            牛心臓浸出物       
             2.0     %   
               ペプトン      
                  0.08   
%                  バクトデキス
トロース            0.02   % 
                 塩化ナトリウム 
                 0.04   %
                  リン酸ナトリウ
ム                0.02   %
    ─────────────────────
─────────                
                         
   pH  7.4
[0011]
Table 1 ──────────────
──────────────────
BHI (DIFCO)
3.7%
calf brain exudate
1.6%
beef heart infusion
2.0%
peptone
0.08
% Bactodextrose 0.02%
sodium chloride
0.04%
Sodium phosphate 0.02%
──────────────────────
─────────

pH 7.4

【0012】添加する油脂は、培
地に対し0.001%〜10%、好ましくは0.002
%〜0.1%を添加することが乳酸菌の増殖及び高度不
飽和脂肪酸の取り込み率からみても望ましい。又乳酸菌
の培地に乳化剤を添加しても良い。
[0012] The amount of oil and fat to be added is 0.001% to 10%, preferably 0.002% to the medium.
% to 0.1% is desirable from the viewpoint of the growth of lactic acid bacteria and the uptake rate of polyunsaturated fatty acids. An emulsifier may also be added to the lactic acid bacteria culture medium.

【0013】このような培地で培養された菌体を凍結乾
燥後、常法により塩酸メタノールにてメチルエステル化
すると、菌体中でエステル結合しているあらゆる脂肪酸
誘導体の脂肪酸組成をGLCで分析できる。又、湿菌体
或は乾燥菌体を有機溶剤などを用いて抽出し、シリカゲ
ルTLCにて脂質を分画した後各々の脂質の構成脂肪酸
を同様にして分析できる。上述の方法により、本発明の
菌体の構成脂肪酸は、ドコサヘキサエン酸、エイコサペ
ンタエン酸、アラキドン酸、リノレイン酸、リノール酸
、オレイン酸、パルミトオレイン酸、パルミチン酸、ミ
リスチン酸などであることがわかった。
[0013] When the bacterial cells cultured in such a medium are freeze-dried and then methyl esterified with hydrochloric acid and methanol by a conventional method, the fatty acid composition of all fatty acid derivatives ester-bonded in the bacterial cells can be analyzed by GLC. . Alternatively, the fatty acids constituting each lipid can be analyzed in the same manner after extracting wet or dry bacterial cells using an organic solvent and fractionating the lipids using silica gel TLC. By the above method, it was found that the fatty acids constituting the bacterial cells of the present invention are docosahexaenoic acid, eicosapentaenoic acid, arachidonic acid, linoleic acid, linoleic acid, oleic acid, palmitoleic acid, palmitic acid, myristic acid, etc. Ta.

【0014】[0014]

【実施例】【Example】

実施例  1 エンテロコッカス・フェシウム(Enterococc
us faecium)IFO−3128をBHI3.
7%、マグロ眼窩脂肪から精製した遊離脂肪酸[ドコサ
ヘキサエン酸(95%)、エイコサペンタエン酸(4%
)]0.05%を含有した培地1L中で嫌気培養し、細
胞を遠心分離して集め、蒸留水で3回洗浄した菌体、更
に0.1%ポリオキシエチレンソルビタンモノオレエ−
ト[Tween 80(登録商標)]水溶液で3回洗浄
した菌体、更に6N塩酸で3回洗浄した菌体を乾燥して
乳酸菌粉末を得た。
Example 1 Enterococcus faecium
us faecium) IFO-3128 to BHI3.
7%, free fatty acids purified from tuna orbital fat [docosahexaenoic acid (95%), eicosapentaenoic acid (4%)]
)] Cells were cultured anaerobically in 1 L of a medium containing 0.05%, centrifuged and collected, and washed three times with distilled water, followed by 0.1% polyoxyethylene sorbitan monooleate.
The bacterial cells washed three times with Tween 80 (registered trademark) aqueous solution and three times with 6N hydrochloric acid were dried to obtain lactic acid bacteria powder.

【0015】各洗浄条件下での乳酸菌の乾燥粉末0.2
gを8%塩酸メタノールに懸濁し、80℃、1時間反応
後生成した脂肪酸メチルエステルをGLCで分析し、高
度不飽和脂肪酸の含有量を定量した。
[0015] Dry powder of lactic acid bacteria under each washing condition: 0.2
g was suspended in 8% hydrochloric acid methanol and reacted at 80° C. for 1 hour, and the resulting fatty acid methyl ester was analyzed by GLC to determine the content of highly unsaturated fatty acids.

【0016】蒸留水で3回洗浄しただけの菌体では、ド
コサヘキサエン酸及びエイコサペンタエン酸の菌体総脂
肪酸に対する割合(乾燥菌体1g当りの含有量)は、各
々87%(220mg)と3%(8mg)であった。
[0016] In the bacterial cells that have been washed only three times with distilled water, the proportions of docosahexaenoic acid and eicosapentaenoic acid to the total fatty acids of the bacterial cells (content per 1 g of dry bacterial cells) are 87% (220 mg) and 3%, respectively. (8 mg).

【0017】0.1%ポリオキシエチレンソルビタンモ
ノオレエ−ト[Tween 80(登録商標)]水溶液
で洗浄した菌体では同様に32%(14mg)と3%(
1.5mg)であった。
Similarly, bacterial cells washed with a 0.1% polyoxyethylene sorbitan monooleate [Tween 80 (registered trademark)] aqueous solution had a concentration of 32% (14 mg) and 3% (
1.5 mg).

【0018】6N塩酸の洗浄を行った菌体は、36%(
19mg)と4%(1.9mg)であった。
[0018] The bacterial cells washed with 6N hydrochloric acid were 36% (
19 mg) and 4% (1.9 mg).

【0019】他の脂肪酸組成は蒸留水で洗浄しただけの
菌体の場合、ミリスチン酸0.1%、パルミチン酸1.
8%、パルミトオレイン酸0.6%、バクセン酸4%で
あった。又、0.1%ポリオキシエチレンソルビタンモ
ノオレエ−ト[Tween 80(登録商標)]水溶液
で洗浄した菌体では同様に1.2%、12.8%、5.
2%、29.4%であった。更に、6N塩酸の洗浄を行
った菌体は、0.7%、11.6%、4.4%、29.
3%であった。
Other fatty acid compositions are 0.1% myristic acid and 1% palmitic acid in the case of bacterial cells that have only been washed with distilled water.
8%, palmitoleic acid 0.6%, and vaccenic acid 4%. Similarly, bacterial cells washed with a 0.1% polyoxyethylene sorbitan monooleate [Tween 80 (registered trademark)] aqueous solution had a concentration of 1.2%, 12.8%, and 5%.
2% and 29.4%. Furthermore, the bacterial cells washed with 6N hydrochloric acid were 0.7%, 11.6%, 4.4%, and 29%.
It was 3%.

【0020】実施例  2 エンテロコッカス・フェカリス(Enterococc
us faecalis)IFO−3181をBHI3
.7%、マグロ眼窩脂肪から精製した遊離脂肪酸[ドコ
サヘキサエン酸(95%)、エイコサペンタエン酸(4
%)]トグリセロールから化学的に合成したモノドコサ
ヘキサノイルグリセロール0.01%を含有した培地1
L中で好気培養し、細胞を遠心分離して集め、蒸留水で
3回洗浄した菌体、更に0.1%ポリオキシエチレンソ
ルビタンモノオレエ−ト[Tween 80(登録商標
)]水溶液で3回洗浄した菌体、更に6N塩酸で3回洗
浄した菌体を5mLの蒸留水に懸濁した後、4倍容のク
ロロホルム/メタノール(2:1)混合液で3回抽出し
た。
Example 2 Enterococcus faecalis
US faecalis) IFO-3181 to BHI3
.. 7%, free fatty acids purified from tuna orbital fat [docosahexaenoic acid (95%), eicosapentaenoic acid (4
%)] Medium 1 containing 0.01% monodocosahexanoylglycerol chemically synthesized from toglycerol
The cells were cultured aerobically in L, collected by centrifugation, and washed three times with distilled water. The cells washed three times and the cells washed three times with 6N hydrochloric acid were suspended in 5 mL of distilled water, and then extracted three times with 4 volumes of a chloroform/methanol (2:1) mixture.

【0021】各洗浄条件の湿菌体から抽出した総脂肪酸
をシリカゲルTLC(展開液:クロロホルム/アセトン
/メタノール=91:8:1)で極性脂質を分画し、常
法に従って、8%塩酸メタノールを用い、80℃、1時
間反応後生成した脂肪酸メチルエステルをGLCで分析
し、高度不飽和脂肪酸の含有量を定量した。蒸留水で洗
浄しただけの菌体極性脂質の構成脂肪酸に占めるドコサ
ヘキサエン酸とエイコサペンタエン酸の割合(乾燥菌体
1g当りの含有量)は、各々13%(26mg)と4%
(8mg)であった。
Polar lipids were fractionated from the total fatty acids extracted from wet bacterial cells under each washing condition using silica gel TLC (developing solution: chloroform/acetone/methanol = 91:8:1), and 8% hydrochloric acid/methanol was added according to a conventional method. After reaction at 80° C. for 1 hour, the fatty acid methyl ester produced was analyzed by GLC to determine the content of highly unsaturated fatty acids. The proportions of docosahexaenoic acid and eicosapentaenoic acid (content per 1 g of dry bacterial cell) in the fatty acids constituting the polar lipids of the bacterial cell just washed with distilled water are 13% (26 mg) and 4%, respectively.
(8 mg).

【0022】0.1%ポリオキシエチレンソルビタンモ
ノオレエ−ト[Tween 80(登録商標)]水溶液
で洗浄した菌体では同様に12%(3.6mg)と4%
(1.2mg)であった。
Similarly, bacterial cells washed with 0.1% polyoxyethylene sorbitan monooleate [Tween 80 (registered trademark)] aqueous solution had a concentration of 12% (3.6 mg) and 4%.
(1.2 mg).

【0023】6N塩酸の洗浄を行った菌体は、9%(2
.7mg)と3%(0.9mg)であった。
[0023] After washing with 6N hydrochloric acid, 9% (2
.. 7 mg) and 3% (0.9 mg).

【0024】他の脂肪酸組成は蒸留水で洗浄しただけの
菌体の場合、ミリスチン酸1.3%、パルミチン酸11
.3%、パルミトオレイン酸6.4%、バクセン酸52
%であった。
[0024] Other fatty acid compositions are myristic acid 1.3% and palmitic acid 11% in the case of bacterial cells that have only been washed with distilled water.
.. 3%, palmitoleic acid 6.4%, vaccenic acid 52
%Met.

【0025】0.1%ポリオキシエチレンソルビタンモ
ノオレエ−ト[Tween 80(登録商標)]水溶液
で洗浄した菌体では同様に1.1%、11.2%、6.
1%、54.6%であった。更に、6N塩酸の洗浄を行
った菌体は、1.4%、11.7%、6.7%、56.
3%であった。
Similarly, bacterial cells washed with a 0.1% polyoxyethylene sorbitan monooleate [Tween 80 (registered trademark)] aqueous solution had a concentration of 1.1%, 11.2%, and 6.
1% and 54.6%. Furthermore, the bacterial cells washed with 6N hydrochloric acid were 1.4%, 11.7%, 6.7%, and 56%.
It was 3%.

【0026】[0026]

【発明の効果】高度不飽和脂肪酸類を含む油脂を添加し
た培地中で乳酸菌を培養することによって、高度不飽和
脂肪酸類を含有した乳酸菌を効率よく短時間で製造する
ことが可能となった。
[Effects of the Invention] By culturing lactic acid bacteria in a medium supplemented with fats and oils containing highly unsaturated fatty acids, it has become possible to efficiently produce lactic acid bacteria containing highly unsaturated fatty acids in a short time.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】  高度不飽和脂肪酸類を含有する乳酸菌
[Claim 1] Lactic acid bacteria containing highly unsaturated fatty acids
【請求項2】  乳酸菌を高度不飽和脂肪酸類又はそれ
らを含む油脂を添加した培地にて培養することを特徴と
する該高度不飽和脂肪酸類を含有する乳酸菌の製造方法
2. A method for producing lactic acid bacteria containing highly unsaturated fatty acids, which comprises culturing the lactic acid bacteria in a medium supplemented with highly unsaturated fatty acids or fats and oils containing them.
JP3139470A 1991-05-16 1991-05-16 Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof Pending JPH04341180A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP3139470A JPH04341180A (en) 1991-05-16 1991-05-16 Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof
JP4147946A JPH05304967A (en) 1991-05-16 1992-05-15 Microorganism, containing highly unsaturated fatty acids and capable of producing lactic acid and its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3139470A JPH04341180A (en) 1991-05-16 1991-05-16 Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof

Publications (1)

Publication Number Publication Date
JPH04341180A true JPH04341180A (en) 1992-11-27

Family

ID=15245994

Family Applications (2)

Application Number Title Priority Date Filing Date
JP3139470A Pending JPH04341180A (en) 1991-05-16 1991-05-16 Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof
JP4147946A Pending JPH05304967A (en) 1991-05-16 1992-05-15 Microorganism, containing highly unsaturated fatty acids and capable of producing lactic acid and its production

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP4147946A Pending JPH05304967A (en) 1991-05-16 1992-05-15 Microorganism, containing highly unsaturated fatty acids and capable of producing lactic acid and its production

Country Status (1)

Country Link
JP (2) JPH04341180A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008167746A (en) * 2006-12-11 2008-07-24 Ajinomoto Co Inc Method for producing l-amino acid
JP2015126741A (en) * 2015-03-02 2015-07-09 株式会社明治 Method for producing fermented milk

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10139674A (en) * 1996-11-11 1998-05-26 Yakult Honsha Co Ltd Production promoter of interleukin 12
JP4124478B2 (en) * 2005-08-22 2008-07-23 学校法人明治大学 Animal feed additives
JP5458536B2 (en) * 2008-09-17 2014-04-02 不二製油株式会社 Method for producing lactic acid and additive for lactic acid fermentation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008167746A (en) * 2006-12-11 2008-07-24 Ajinomoto Co Inc Method for producing l-amino acid
JP2015126741A (en) * 2015-03-02 2015-07-09 株式会社明治 Method for producing fermented milk

Also Published As

Publication number Publication date
JPH05304967A (en) 1993-11-19

Similar Documents

Publication Publication Date Title
JP7134938B2 (en) Eicosapentaenoic Acid Producing Microorganisms, Fatty Acid Compositions, and Methods of Making and Using Them
KR101451415B1 (en) Process for producing microbial fat or oil having lowered unsaponifiable matter content and said fat or oil
JP3985035B2 (en) (N-6) Docosapentaenoic Acid-Containing Oil and Fat, Method for Producing the Oil and Use, and Use
EP0823475B1 (en) Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms
AU661674B2 (en) Arachidonic acid and methods for the production and use thereof
JP4518674B2 (en) Use of docosapentaenoic acid-containing substances
US7470527B2 (en) Preparation of microbial oil
CA2675691C (en) Methods for producing polyunsaturated fatty acid and lipid containing polyunsaturated fatty acid
JP2008136493A (en) Method for production of arachidonic acid
JPH078215A (en) Marine microalgal food raw material containing docosahexaenoic acid and its production
IL128166A (en) Process for preparing docosahexaenoic acid and docosapentaenoic acid
JPH01215245A (en) Animal feed containing highly unsaturated fatty acid added thereto
JPH04341180A (en) Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof
KR20060079789A (en) Use of a single-cell protein material
JPS6087798A (en) Production of eicosapentaenoic acid by algae
JP3044577B2 (en) Production of photosynthetic bacteria containing polyunsaturated fatty acids
JP7262536B2 (en) Lipid composition, use thereof and method for producing the same
JP2001245687A (en) Lipid containing n-4 and/or n-7 highly unsaturated fatty acid and method for producing the lipid
JP3502903B2 (en) Method for producing polyunsaturated fatty acid and polyunsaturated phospholipid
JPH08163990A (en) Oil-and-fat-containing alga and production of oil-and-fat derived therefrom
JPH0723774A (en) Lactic bacterium containing docosahexaenoic acid and its production
JP2002335951A (en) Method for producing lipid-containing yeast
JPH0484892A (en) Production of eicosapentaenoic acid
JPH11343236A (en) Medicinal composition containing polybasic unsaturated fatty acid and health food